InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Koven Andrew I, 董事. Officer active across 5 companies, notably Kala Pharmaceuticals, Inc.. In total, 9 reports have been published. Activity tracked since 17 June 2021. The latest transaction was filed on 30 June 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Koven Andrew I
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
28,147 股0Common StockSEC:0001104659-25-064706:0
3,050 股0Common StockSEC:0001415889-25-017611:0
1,750 股0Common StockSEC:0001415889-24-016570:0
5,051 股0Common StockSEC:0001104659-24-069786:0
87,500 股0Common StockSEC:0001104659-23-084992:0
7,515 股0Common StockSEC:0001415889-23-010288:0
2,197 股Common StockSEC:0001415889-23-009140:0
25,000 股0Common StockSEC:0001415889-21-003121:0
1,476,674 股Common SharesSEC:0001104659-16-095183:0
9 条申报中的 9 条
About Koven Andrew I
KOVEN ANDREW I is Administrateur and has 9 filings in total. The sampled recent filings run from 2016-02-09 to 2025-07-01 and show attribution transactions, with buy and sell amounts of EUR 0 in this sample.
